Episode

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Podcast: Lung Cancer Update
Published: Apr 27, 2026
Duration seconds: 3446
Processing state: not_requested
Canonical source: https://lung-cancer-update.captivate.fm/episode/6011-yir2025-egfrnsclc
Audio: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/ee596c70-4da8-401a-a91a-1209dd1b9a77.mp3
JSON: /v1/public/podcasts/lung-cancer-update-827388/episodes/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances
Markdown: /podcast/lung-cancer-update-827388/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md

Actions

POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/lung-cancer-update-827388/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported over the past year. CME information and select publications here .